In Q1 2018, the prices for drugs and other pharmaceuticals rose by 7% in the Republic of Kazakhstan. Prices for pharmaceutical products increased by 2% compared to the previous quarter and by 6.6% compared to the same period a year earlier.
The most significant annual price increase was registered in the segment of hormonal drugs (a 20.5% jump). A similarly strong hike was reported for analgesics (12.7% over the year) and stomachics (9.1% year-on-year).
In the first two months of 2018, the pharmaceutical companies operating in the Republic of Kazakhstan manufactured 4.12 thousand tons of medicines, which is 45.4% more than a year earlier. Traditionally, the largest volume was reported in Almaty region and the city of Almaty (49.9% and 19.3% of the total output in Kazakhstan, respectively), as well as in South Kazakhstan region (13.2% of the total output in Kazakhstan).
These top three regions are hosting the operations of such major companies as AbdiIbachem GlobalPharm LLP, Kelun-KazPharm LLP, Dolce LLP (Almaty region), Nobel Almaty Pharmaceutical Factory, Aurora LLP, Cheminnova Alimor Kazpharm LLP, Rapid-Alimor Industries Pharm LLP, Dosfarm LLP (Almaty), Zerde-Fito LLP, Chempharm JSC (South Kazakhstan region), and others.
In value terms, the output of basic pharmaceutical products reached 13.19 billion tenge in January-February 2018, which is 13% more than in the same period of last year.